For research use only. Not for therapeutic Use.
Brilaroxazine(Cat No.:I015427)is an orally active small molecule with a unique serotonin–dopamine stabilizing profile. Acting on dopamine D2/D3 and serotonin 5-HT1A, 5-HT2A, and 5-HT7 receptors, it balances neurotransmission while minimizing common side effects of traditional antipsychotics. Brilaroxazine has been investigated in clinical studies for schizophrenia, psychosis, and inflammatory conditions, demonstrating antipsychotic, antidepressant, and anti-inflammatory potential. Its multimodal mechanism makes it a promising therapeutic candidate for central nervous system and immune-related disorders. Researchers use brilaroxazine to explore novel approaches in neuropsychiatric and immunology research.
CAS Number | 1239729-06-6 |
Synonyms | 6-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-4H-1,4-benzoxazin-3-one |
Molecular Formula | C22H25Cl2N3O3 |
Purity | ≥95% |
IUPAC Name | 6-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-4H-1,4-benzoxazin-3-one |
InChI | InChI=1S/C22H25Cl2N3O3/c23-17-4-3-5-19(22(17)24)27-11-9-26(10-12-27)8-1-2-13-29-16-6-7-20-18(14-16)25-21(28)15-30-20/h3-7,14H,1-2,8-13,15H2,(H,25,28) |
InChIKey | PMKMNTBZJOXTJW-UHFFFAOYSA-N |
SMILES | C1CN(CCN1CCCCOC2=CC3=C(C=C2)OCC(=O)N3)C4=C(C(=CC=C4)Cl)Cl |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |